MRI for Myositis: Contrast Recommendation
For suspected myositis, MRI without contrast is sufficient for initial diagnosis, with contrast reserved for specific clinical scenarios including suspected abscess, necrosis, vascular complications, or when initial non-contrast findings are equivocal. 1
Initial Imaging Approach
Both contrast-enhanced and non-contrast MRI are considered equivalent alternatives for diagnosing musculoskeletal inflammatory conditions, including myositis. 1 The American College of Radiology explicitly states these modalities have equal appropriateness ratings for initial evaluation. 1
Optimal MRI Protocol
- T2-weighted and STIR (Short Tau Inversion Recovery) sequences are the preferred protocols for detecting muscle inflammation, as they enhance visualization of edema and inflammatory changes characteristic of myositis. 1
- Non-contrast MRI effectively identifies muscle edema patterns that distinguish active inflammation from chronic damage (atrophy/fat replacement). 2
- MRI can detect muscle inflammation even when clinical signs are absent, making it highly sensitive for early disease. 1
When to Add Contrast
Reserve contrast administration for the following specific scenarios: 1
- Suspected abscess or necrosis - Contrast helps delineate areas of tissue destruction and fluid collections requiring drainage 1
- Vascular complications - When assessing muscle perfusion patterns or vascular involvement 1
- Equivocal non-contrast findings - When initial imaging does not provide diagnostic clarity 1
- Guiding biopsy site selection - Particularly in atypical presentations where tissue diagnosis is needed 1
Integration with Other Diagnostic Tools
MRI should never serve as the sole diagnostic tool for myositis. 1 A comprehensive diagnostic approach includes:
- Clinical examination findings (muscle weakness is more typical than pain) 3
- Laboratory values: creatine kinase (CK), aldolase, inflammatory markers (ESR, CRP), troponin for cardiac involvement 3
- Electromyography (EMG) when diagnosis is uncertain or neurologic overlap suspected 3
- Muscle biopsy for definitive diagnosis, especially in atypical presentations 1
- Autoantibody testing for myositis-specific antibodies 3
Monitoring Disease Activity
MRI is highly effective for serial monitoring of treatment response and disease activity over time. 1 Non-contrast sequences remain adequate for follow-up imaging, as they can:
- Distinguish active inflammation (edema on T2/STIR) from chronic damage (fat replacement) 2
- Guide therapy adjustments by determining whether weakness relates to active inflammation or irreversible damage 2
- Assess response to immunosuppressive treatment 1
Common Pitfalls to Avoid
- Do not delay treatment for MRI - In acute presentations with high clinical suspicion, empiric treatment should not be postponed for imaging 3
- Avoid misinterpreting myositis mimics - Many conditions (muscular dystrophies, denervation, diabetic myonecrosis, deep venous thrombosis, muscle injury) can produce similar MRI findings 4
- Ensure expert interpretation - MRI should be interpreted by a radiologist experienced in musculoskeletal imaging to accurately assess inflammatory changes 1
- Consider corticosteroid effects - Prior corticosteroid treatment may abolish inflammatory infiltrations on biopsy despite persistent MRI abnormalities 5
Practical Implementation Algorithm
- Start with non-contrast MRI using T2-weighted/STIR sequences for all suspected myositis cases 1
- Add contrast only if:
- Integrate MRI findings with CK, aldolase, EMG, and clinical examination 3, 1
- Use MRI to target biopsy sites when tissue diagnosis required 1
- Employ non-contrast MRI for treatment monitoring 1, 2